CSIMarket
 

Pliant Therapeutics Inc   (PLRX)
Other Ticker:  
 

Pliant Therapeutics Inc 's Working Capital Per Sales

PLRX's Working Capital and Revenue growth



PLRX Working Capital Per Revenue (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Working Capital Change 49.19 % 255.15 % 238.26 % 64.27 % 57.57 %
Y / Y Revenue Change - -95.03 % 6.65 % -1.7 % -7.95 %
Working Capital Per Revenue 135.73 87.4 35.12 25.15 21.88
Total Ranking # # # # #
Seq. Working Capital Change -5.45 % -5.11 % 78.6 % -6.89 % 125.08 %
Seq. Revenue Change - -81.38 % -32.21 % 32.59 % -70.29 %





Comment on PLRX's Working Capital Per Revenue in the third quarter 2023
Pliant Therapeutics Inc 's Working Capital Per Revenue sequentially grew to 135.73 during the Q3 2023, above the company average. Due to increase of revenue in the Q3 2023 year on year by -100%.

Within Healthcare sector Pliant Therapeutics Inc has achieved the lowest Working Capital Per Revenue. While Working Capital Per Revenue remained unchanged in the Q3 2023 relative to the prior quarter at no. .
Working Capital Per Revenue Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Working Capital Per Revenue Statistics
High Average Low
0
0
0
 



Financial Statements
Pliant Therapeutics Inc 's Working Capital $ 507 Millions Visit PLRX's Balance sheet
Pliant Therapeutics Inc 's Revenues $ 0 Millions Visit PLRX's Income Statement
Where are PLRX's Sales coming from? Visit PLRX's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Sep 30 2023, within Healthcare Sector Working Capital Per Revenue
Ovid Therapeutics Inc   347.71 
China Health Industries Holdings Inc   313.01 
Inmune Bio Inc   191.03 
Chimerix Inc   175.78 
Sera Prognostics Inc   164.50 
Pluri Inc   150.48 
Aim Immunotech Inc   142.13 
Onconova Therapeutics inc   110.28 
Shattuck Labs Inc   98.24 
Bioxcel Therapeutics Inc   96.88 
Fulcrum Therapeutics Inc   95.05 
Sage Therapeutics Inc   90.85 
Akili Inc   87.71 
Singular Genomics Systems Inc   86.26 
Fusion Pharmaceuticals Inc   84.21 
Century Therapeutics inc   81.75 
Cytokinetics Incorporated  74.24 
Oncternal Therapeutics Inc   73.83 
Crinetics Pharmaceuticals Inc   73.35 
Synlogic Inc   66.68 
Verve Therapeutics Inc   62.81 
Inhibikase Therapeutics Inc   61.48 
Lyra Therapeutics Inc   60.93 
Vivos Inc  59.71 
Celldex Therapeutics inc   59.61 
Avidity Biosciences Inc   53.67 
Talis Biomedical Corporation  45.40 
Bridgebio Pharma Inc   44.76 
Astrotech Corp  38.12 
Janux Therapeutics Inc   37.01 
Date modified: 2023-11-12T03:39:20+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com